Recent Quotes (30 days)

You have no recent quotes
chg | %

Innovotech Inc  

(Public, CVE:IOT)   Watch this stock  
Find more results for IOT
0.0150
0.0000 (0.00%)
Mar 26 - Close
CVE data delayed by 15 mins - Disclaimer
Currency in CAD
Range     -
52 week 0.01 - 0.12
Open     -
Vol. 0.00
Mkt cap 431,090.00
P/E     -
Div/yield     -
EPS -0.02
Shares 28.74M
Beta -0.16
Inst. own     -

Key stats and ratios

Q3 (Sep '14) 2013
Net profit margin -97.85% -93.07%
Operating margin -84.12% -86.29%
EBITD margin - -80.08%
Return on average assets -159.93% -122.32%
Return on average equity - -
Employees 16 -
CDP Score - -

Address

Suite 101, 2011-94 Street
EDMONTON, AB T6N 1H1
Canada
+1-780-4480585 (Phone)
+1-780-4240941 (Fax)

Website links

Description

Innovotech Inc is a Canada-based company, which develops products to address bacterial biofilm problems. The Company�s contract research services provide medical device companies with scientific studies that are one of the components of regulatory applications to the United States Food and Drug Administration and other agencies. The Company�s InnovoSCEP veterinary product line provides veterinarians guidance on antibiotic selection for chronic biofilm infections. Innovotech Inc�s MBEC Assay is a research tool utilized by universities, research institutes and corporations for research on biofilms. It has provided solutions for catheter and implant medical devices, antibiotic drug development, wound healing, paint and specialized coatings, water system antimicrobial agents, dental treatments and water line antimicrobial agents, bacterial and fungal agricultural crop diseases, and hard surface disinfectants in food safety, transportation and health care.

Officers and directors

James Timourian Ph.D. Chairman of the Board, President, Chief Financial Officer
Bruce Darryl Hirsche Q.C. Corporate Secretary, Director
Age: 66
Bernard Grobbelaar Director
Robert Huizinga Director
Wolfgang H. Muhs Ph.D. Independent Director
Gerard Tertzakian Ph.D. Independent Director